← Back to Search

Other

JZP150 for Post-Traumatic Stress Disorder

Phase 2
Waitlist Available
Research Sponsored by Jazz Pharmaceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Many of those who suffer from PTSD use cannabis. If you use cannabis, are you willing to refrain from cannabis use during the duration of the study (approximately 18 weeks)?
Did you experience a traumatic event within the last 9 years?
Must not have
Is your PTSD due to war combat?
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to week 12
Awards & highlights

Study Summary

This trial will study whether JZP150 is a safe and effective treatment for adults with PTSD.

Eligible Conditions
  • Post Traumatic Stress Disorder

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean Change from Baseline to Week 12 in Clinician Administered Posttraumatic Stress Disorder (PTSD) Scale (CAPS-5) Total Symptom Severity Score
Secondary outcome measures
Mean Change from Baseline to Week 12 in Clinical Global Impression of Severity (CGI-S)
Mean Change from Baseline to Week 12 in Patient Global Impression of Severity (PGI-S)

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: JZP150 4.0 mgExperimental Treatment1 Intervention
Participants who will be randomized to receive JZP150 4.0 mg orally once daily for up to 12 weeks.
Group II: JZP150 0.3 mgExperimental Treatment1 Intervention
Participants who will be randomized to receive JZP150 0.3 mg orally once daily for up to 12 weeks.
Group III: PlaceboPlacebo Group1 Intervention
Participants who will be randomized to receive placebo orally once daily for up to 12 weeks.

Who is running the clinical trial?

Jazz PharmaceuticalsLead Sponsor
248 Previous Clinical Trials
34,089 Total Patients Enrolled

Media Library

JZP150 (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05178316 — Phase 2
Post-Traumatic Stress Disorder Research Study Groups: Placebo, JZP150 0.3 mg, JZP150 4.0 mg
Post-Traumatic Stress Disorder Clinical Trial 2023: JZP150 Highlights & Side Effects. Trial Name: NCT05178316 — Phase 2
JZP150 (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05178316 — Phase 2
Post-Traumatic Stress Disorder Patient Testimony for trial: Trial Name: NCT05178316 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research still looking for participants?

"This study is currently looking for patients, according to the clinicaltrials.gov website. The original posting date was December 29th, 2021, and the most recent edit was on October 17th, 2022."

Answered by AI

Does this research project have an age limit?

"This specific trial requires that patients be between 18-70 years old, which 297 other studies also demand of their participants. 887 other clinical trials have different age requirements, some of which allow for patients over 65."

Answered by AI

Is this trial being conducted in more than one hospital?

"The trial is based in NRC Research Institute (Orange, CA), Collaborative Neuroscience Research, LLC (Torrance, FL), EZY Medical Research Co (Miami, CO), and other locations."

Answered by AI

How many people are enrolled in this clinical trial?

"In order to conduct this clinical trial, 270 participants that fit the pre-defined criteria are needed. These individuals can join the study at either NRC Research Institute located in Orange, California or Collaborative Neuroscience Research, LLC based out of Torrance, Florida."

Answered by AI

What is the regulatory status of JZP150?

"JZP150's safety is supported by some data, but since this is only a Phase 2 trial, there is no information yet on whether the medication is effective."

Answered by AI

Are there any specific prerequisites for subjects in this experiment?

"The ideal candidates for this clinical trial are those aged 18 to 70 who have a PTSD diagnosis. A total of 270 patients are needed. Other key inclusion criteria include:"

Answered by AI

Who else is applying?

What state do they live in?
California
Oklahoma
Other
Texas
How old are they?
65+
18 - 65
What site did they apply to?
Paradigm Research Professionals, LLC
Pillar Clinical Research, LLC
Relaro Medical Trials, LLC
Other
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
2
1
3+
0

What questions have other patients asked about this trial?

How fast can I start? How long is this study for? How much does this trial pay?
PatientReceived 2+ prior treatments
How long do screening visits take? And how often will I have to come into the office?
PatientReceived 2+ prior treatments

Why did patients apply to this trial?

I want a normal life. I want to understand. I want a normal life. Yes I would like to text.
PatientReceived 2+ prior treatments
standard drugs do not seem to help.
PatientReceived no prior treatments

How responsive is this trial?

Most responsive sites:
  1. Relaro Medical Trials, LLC: < 24 hours
  2. CITrials: < 24 hours
  3. Richmond Behavioral Associates: < 48 hours
Average response time
  • < 2 Days
Typically responds via
Email
Phone Call
Recent research and studies
clinicaltrials.govStudy
A Study of JZP150 in Adults With Posttraumatic Stress Disorder
2021. "A Study of JZP150 in Adults With Posttraumatic Stress Disorder". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05178316.
~83 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top